Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal J Gao, BA Aksoy, U Dogrusoz, G Dresdner, B Gross, SO Sumer, Y Sun, ... Science Signaling, scisignal. 2004088v1, 2013 | 13907 | 2013 |
Comprehensive molecular portraits of human breast tumours TCGA Network (TCGA) Nature 490, 61-70, 2012 | 11190* | 2012 |
Comprehensive molecular characterization of human colon and rectal cancer Cancer Genome Atlas Network Nature 487 (7407), 330, 2012 | 7531 | 2012 |
Comprehensive molecular characterization of gastric adenocarcinoma Cancer Genome Atlas Research Network Nature 513 (7517), 202, 2014 | 5230 | 2014 |
Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4937 | 2013 |
Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 | 3900 | 2014 |
Comprehensive genomic characterization of squamous cell lung cancers. PS Hammerman, DN Hayes, MD Wilkerson, N Schultz, R Bose, A Chu, ... Nature 489 (7417), 519-525, 2012 | 3689* | 2012 |
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015 | 2937 | 2015 |
Comprehensive molecular characterization of clear cell renal cell carcinoma. TCGA Network (TCGA) Nature, 2013 | 2847* | 2013 |
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2717 | 2015 |
Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2655 | 2014 |
Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014 | 2557 | 2014 |
Evaluating cell lines as tumour models by comparison of genomic profiles S Domcke*, R Sinha*, DA Levine, C Sander, N Schultz Nature Communications, 2013 | 1509 | 2013 |
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ... The Journal of clinical investigation 126 (3), 1052-1066, 2016 | 1088 | 2016 |
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network E Collisson, J Campbell, A Brooks, A Berger, W Lee, J Chmielecki, D Beer, ... Nature 511 (7511), 543-550, 2014 | 836 | 2014 |
The mutational landscape of adenoid cystic carcinoma AS Ho, K Kannan, DM Roy, LGT Morris, I Ganly, N Katabi, D Ramaswami, ... Nature genetics 45 (7), 791-798, 2013 | 470 | 2013 |
Comparative genomic analysis of primary versus metastatic colorectal carcinomas E Vakiani, M Janakiraman, R Shen, R Sinha, Z Zeng, J Shia, A Cercek, ... Journal of clinical oncology 30 (24), 2956-2962, 2012 | 306 | 2012 |
The molecular diversity of Luminal A breast tumors G Ciriello, R Sinha, KA Hoadley, AS Jacobsen, B Reva, CM Perou, ... Breast cancer research and treatment 141, 409-420, 2013 | 173 | 2013 |
Association of high tumor mutation burden in non–small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 … B Ricciuti, X Wang, JV Alessi, H Rizvi, NR Mahadevan, YY Li, A Polio, ... JAMA oncology 8 (8), 1160-1168, 2022 | 169 | 2022 |
Combined analysis of metabolomes, proteomes, and transcriptomes of hepatitis C virus–infected cells and liver to identify pathways associated with disease development J Lupberger, T Croonenborghs, AAR Suarez, N Van Renne, F Jühling, ... Gastroenterology 157 (2), 537-551. e9, 2019 | 93 | 2019 |